Form 8-K - Current report:
SEC Accession No. 0001193125-25-161239
Filing Date
2025-07-18
Accepted
2025-07-18 16:30:41
Documents
13
Period of Report
2025-07-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d45208d8k.htm   iXBRL 8-K 28324
2 EX-16.1 d45208dex161.htm EX-16.1 1877
  Complete submission text file 0001193125-25-161239.txt   146545

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20250716.xsd EX-101.SCH 2878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20250716_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20250716_pre.xml EX-101.PRE 11280
16 EXTRACTED XBRL INSTANCE DOCUMENT d45208d8k_htm.xml XML 3658
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 251134847
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)